Close Menu

Novartis Goes First

Novartis' CAR-T cell therapy is now the first of its kind to be approved by the FDA, reports Marketwatch. The pharmaceutical company's Kymriah, the first gene therapy available in the US, will be accessible to young people up to age 25 with a form of acute lymphoblastic leukemia.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers representing scientists and students of Chinese descent voice their concerns about recent US policies and rhetoric.

Wired reports that researchers have shown they could reprogram a DNA-based computer.

Researchers say increased diversity in genomic studies will benefit all, PBS NewsHour reports.

In Science this week: whole-genome sequencing of single sperm cells, and more.